blueashtx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Blue Ash |
| Description | Blue Ash Therapeutics Home About Us Publications In the News Contact Us Blue Ash Therapeutics, LLC (BAT) is a privately funded company, formed in Decemb |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.22.44.57 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
blueashtx.com Valuation
|
US$703,501
Last updated: 2023-05-12 07:40:17
blueashtx.com has Semrush global rank of 15,045,190. blueashtx.com has an estimated worth of US$ 703,501, based on its estimated Ads revenue. blueashtx.com receives approximately 81,174 unique visitors each day. Its web server is located in United States, with IP address 165.22.44.57. According to SiteAdvisor, blueashtx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$703,501 |
| Daily Ads Revenue | US$650 |
| Monthly Ads Revenue | US$19,482 |
| Yearly Ads Revenue | US$233,779 |
| Daily Unique Visitors | 5,412 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| blueashtx.com. | A | 7199 | IP: 165.22.44.57 |
| blueashtx.com. | NS | 7200 | NS Record: ns1.hostica.com. |
| blueashtx.com. | NS | 7200 | NS Record: ns2.hostica.com. |
| blueashtx.com. | NS | 7200 | NS Record: ns3.hostica.com. |
| blueashtx.com. | MX | 7200 | MX Record: 20 blueashtx.com.2.0001.arsmtp.com. |
| blueashtx.com. | MX | 7200 | MX Record: 10 blueashtx.com.1.0001.arsmtp.com. |
| blueashtx.com. | TXT | 7200 | TXT Record: v=spf1 ptr:exghost.com ptr:appriver.com ~all |
HtmlToTextCheckTime:2023-05-12 07:40:17
| Blue Ash Therapeutics Home About Us Publications In the News Contact Us Blue Ash Therapeutics, LLC (BAT) is a privately funded company, formed in December 2008 in Cincinnati to bring a promising cardiovascular drug – azimilide - to market. BAT acquired the license for global development of azimilide dihydrochloride from Warner Chilcott in January 2010. After reactivating the azimilide IND, BAT formed a Cincinnati-based clinical and regulatory development team that met with the FDA and gained agreement, via the Special Protocol Assessment (SPA) process, for the design and sizing of a single Phase III trial as the final efficacy study needed for marketing approval. In April 2011 the azimilide license and global development rights were purchased from BAT by Forest Labs, Inc. who will assume responsibility for the Phase III development program. Through an asset purchase agreement, Forest was assigned the license agreement between Warner Chilcott Company and BAT, providing for worldwide |
HTTP Headers
HTTP/1.1 200 OK Connection: Keep-Alive Keep-Alive: timeout=5, max=100 content-type: text/html last-modified: Mon, 15 Apr 2013 17:13:38 GMT accept-ranges: bytes content-length: 3082 date: Mon, 06 Dec 2021 08:27:55 GMT server: LiteSpeed vary: User-Agent |
blueashtx.com Whois Information
Domain Name: BLUEASHTX.COM Registry Domain ID: 1589418532_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-11T21:58:13Z Creation Date: 2010-03-19T17:59:16Z Registry Expiry Date: 2022-03-19T17:59:16Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.HOSTICA.COM Name Server: NS2.HOSTICA.COM Name Server: NS3.HOSTICA.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-09T07:29:56Z <<< |